$8.62
0.121.41%
Last update: Nov 5, 6:43 PM
Xilio Therapeutics Inc (XLO) Stock Price, Quote, News & History
XLONASDAQ
AbbVie and Xilio partner to develop tumor-activated immunotherapies. Xilio's pipeline includes masked T cell engagers for prostate, gastric, and lung cancers.
You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.
Other companies in Xilio Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Xilio Therapeutics has a consensus price target of $33.33.
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $8.25 last updated November 5, 2026 at 6:43 PM EST.
There are no upcoming dividends for Xilio Therapeutics.
Xilio Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Xilio Therapeutics.
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology...
